Clinical Trial Update: The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating evolocumab in patients with diabetes and atherosclerotic vascular disease; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Vascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Robert Rosenson | Conditions: Atherosclerotic Vascular Disease, Type2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2023-03-08